Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure allows for selective binding to enzyme active sites, making it valuable in developing drugs that modulate cellular signaling pathways. Commonly employed in the preparation of small-molecule inhibitors targeting BTK (Bruton's tyrosine kinase) and other tyrosine kinases involved in immune response and tumor growth. Also utilized in radiolabeling studies due to the presence of iodine, enabling imaging and tracer applications in preclinical research.